These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22559930)

  • 1. Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor γ.
    Castell AL; Hiéronimus S; Lascols O; Fournier T; Fénichel P
    Diabetes Metab; 2012 Oct; 38(4):367-9. PubMed ID: 22559930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.
    Lüdtke A; Buettner J; Schmidt HH; Worman HJ
    J Med Genet; 2007 Sep; 44(9):e88. PubMed ID: 17766367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
    Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
    Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
    Hegele RA; Ur E; Ransom TP; Cao H
    Clin Genet; 2006 Oct; 70(4):360-2. PubMed ID: 16965332
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
    Monajemi H; Zhang L; Li G; Jeninga EH; Cao H; Maas M; Brouwer CB; Kalkhoven E; Stroes E; Hegele RA; Leff T
    J Clin Endocrinol Metab; 2007 May; 92(5):1606-12. PubMed ID: 17299075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ and human trophoblast differentiation.
    Fournier T; Guibourdenche J; Handschuh K; Tsatsaris V; Rauwel B; Davrinche C; Evain-Brion D
    J Reprod Immunol; 2011 Jun; 90(1):41-9. PubMed ID: 21704384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
    Jeninga EH; van Beekum O; van Dijk AD; Hamers N; Hendriks-Stegeman BI; Bonvin AM; Berger R; Kalkhoven E
    Mol Endocrinol; 2007 May; 21(5):1049-65. PubMed ID: 17312272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARgamma and early human placental development.
    Fournier T; Thérond P; Handschuh K; Tsatsaris V; Evain-Brion D
    Curr Med Chem; 2008; 15(28):3011-24. PubMed ID: 19075649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of peroxisome proliferator-activated receptor gamma activation by its endogenous ligand 15-deoxy Delta12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women.
    Jawerbaum A; Capobianco E; Pustovrh C; White V; Baier M; Salzberg S; Pesaresi M; Gonzalez E
    Mol Hum Reprod; 2004 Sep; 10(9):671-6. PubMed ID: 15258247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma in normal human pregnancy and miscarriage.
    Toth B; Bastug M; Mylonas I; Scholz C; Makovitzky J; Kunze S; Thaler C; Friese K; Jeschke U
    Acta Histochem; 2009; 111(4):372-8. PubMed ID: 19342081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of genetic variation of PPARgamma in humans.
    Meirhaeghe A; Amouyel P
    Mol Genet Metab; 2004; 83(1-2):93-102. PubMed ID: 15464424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from human mutations in PPARgamma.
    Hegele RA
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S31-5. PubMed ID: 15711581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma-ligand-binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration.
    Shoaito H; Chauveau S; Gosseaume C; Bourguet W; Vigouroux C; Vatier C; Pienkowski C; Fournier T; Degrelle SA
    J Cell Mol Med; 2020 Jul; 24(13):7660-7669. PubMed ID: 32519441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction.
    Rodie VA; Young A; Jordan F; Sattar N; Greer IA; Freeman DJ
    J Soc Gynecol Investig; 2005 Jul; 12(5):320-9. PubMed ID: 15979543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient.
    Chen X; Ma Z; Chen P; Song X; Li W; Yu X; Xie J
    Front Endocrinol (Lausanne); 2022; 13():830708. PubMed ID: 35422762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation.
    Madhra M; Noh RM; Zammitt NN; Patrick AW; Love CD
    Diabet Med; 2012 Oct; 29(10):e398-401. PubMed ID: 22803842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the transactivation deficiency of the human PPARγ F360L mutant associated with familial partial lipodystrophy.
    Lori C; Pasquo A; Montanari R; Capelli D; Consalvi V; Chiaraluce R; Cervoni L; Loiodice F; Laghezza A; Aschi M; Giorgi A; Pochetti G
    Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1965-76. PubMed ID: 25004973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C).
    Visser ME; Kropman E; Kranendonk ME; Koppen A; Hamers N; Stroes ES; Kalkhoven E; Monajemi H
    Diabetologia; 2011 Jul; 54(7):1639-44. PubMed ID: 21479595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.